Clinical Trials Browser

Phase 1/2 × Disease Attributes × fludarabine × Clear all

NCT05826535 2026-02-24

Study of LYL314 in Aggressive Large B-Cell Lymphoma

Immune System Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Disease Attributes